Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_224c7b63a0ea6f06a25a800087b1caf5 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-05 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0402 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F7-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F3-003 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B59-002 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-94 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0497 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K103-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K103-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04 |
filingDate |
2018-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_617f6b252e10135d8bf781f153d0545f |
publicationDate |
2020-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
BR-112020011789-A2 |
titleOfInvention |
complex comprising a psma bleaching compound attached to a lead or thorium radionuclide |
abstract |
the present invention relates to complexes comprising a targeting compound of a prostate-specific membrane antigen (psma) attached to a radionuclide, such as 212bp or 227th, through a chelating tcmc or dota fraction. these compounds, and pharmaceutical compositions that comprise them, can be used for medical applications. these applications include the treatment of prostate cancer, and the complexes allow double targeting of cancers. |
priorityDate |
2017-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |